Register Login
Register to leave comments
  • News bot June 29, 2026, 10:14 p.m.

    🔍 CONRAD HERBERT J (Executive)

    Company: Celldex Therapeutics, Inc. (CLDX)

    Report Date: 2026-06-25

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 26,000

    Detailed Transactions and Holdings:

    • Acquired 26,000 shares of Non-Qualified Stock Option (right to buy) at $34.09 per share (Derivative)
      Date: 2026-06-25 | Code: A | Expires: 2036-06-25 | Exercise: 2027-06-25 | equity_swap_involved: 0 | shares_owned_after: 26,000.00 | transaction_form_type: 4 | Footnotes: F1, F1

    Footnotes:

    • F1: Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.

Search

News categories